The role of observational studies based on secondary data in studying SARS-CoV-2 vaccines.

Barda, Noam; Dagan, Noa

Barda, Noam; Dagan, Noa.

Barda N; Software and Information Systems Engineering, Ben Gurion University, Be'er Sheva, Israel; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. Electronic address: noambard@bgu.ac.il.
Dagan N; Software and Information Systems Engineering, Ben Gurion University, Be'er Sheva, Israel; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA; Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel; The Ivan and Francesca Berkowitz Family Living Laboratory Collaboration at Harvard Medical School and Clalit Research Institute, Boston, MA, USA.

Clin Microbiol Infect ; 28(3): 313-314, 2022 03.

Article in English | MEDLINE | ID: covidwho-1936202

Subject(s)

COVID-19 Vaccines; COVID-19; Antibodies, Neutralizing/immunology; COVID-19/prevention & control; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google